NCT00924027 2025-09-05A Study of Patients Receiving High-Dose Rate BrachytherapyNational Institutes of Health Clinical Center (CC)Phase 2 Completed43 enrolled 13 charts
NCT03482102 2022-09-08Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract CancerMassachusetts General HospitalPhase 2 Recruiting70 enrolled